Pentafecta evaluation in robot-assisted radical prostatectomy by risk group




Víctor E. Corona-Montes, Departamento de Urología y Cirugía Robótica, Centro Médico A.B.C. (American British Cowdray) Observatorio; Servicio de Urología, Hospital General de México Dr. Eduardo Liceaga; Centro de Cirugía Robótica, Hospital Ángeles del Pedregal; Centro de Cirugía Robótica, San Ángel Inn Universidad; Ciudad de México, México
Juan E. Sánchez-Núñez, Servicio de Urología, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Rocío N. Gómez-López, Departamento de Urología y Cirugía Robótica, Centro Médico A.B.C. (American British Cowdray) Observatorio, Ciudad de México, México
Gerardo Fernández-Noyola, Servicio de Urología, Hospital General Dr. Manuel Gea González. Ciudad de México, México


Objective: Radical prostatectomy is a therapeutic option in organ-confined prostate cancer. As the development of robotic systems progresses, the approach with this technology has begun to impact the functional and oncological outcomes of urological patients. The objective is to report the rate of pentafecta in patients undergoing robot-assisted radical prostatectomy (RARP) stratified by risk groups. Method: Retrospective, observational, descriptive study from 2013 to 2020 that included 112 patients undergoing RARP. Results: A rate of pentafecta at 12 months of follow-up of 35.7% (n = 40) was obtained. In the subanalysis by risk groups, at 1-year follow-up, was obtained an index of 43% (n = 26), 26% (n = 9) and 22% (n = 4) in low-, intermediate-, and high-risk patients, respectively. Conclusions: Prostatectomy showed functional and oncological results similar to those reported in the literature with robotic approach, regardless of the risk group for prostate cancer.



Keywords: Prostate cancer. Robotic surgery. Urology.